Logo image of BIRD

ALLBIRDS INC-CL A (BIRD) Stock Fundamental Analysis

NASDAQ:BIRD - Nasdaq - US01675A2087 - Common Stock - Currency: USD

6.61  -0.29 (-4.2%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BIRD. BIRD was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While BIRD has a great health rating, there are worries on its profitability. BIRD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BIRD had negative earnings in the past year.
BIRD had a negative operating cash flow in the past year.
BIRD had negative earnings in each of the past 5 years.
In the past 5 years BIRD reported 4 times negative operating cash flow.
BIRD Yearly Net Income VS EBIT VS OCF VS FCFBIRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -56.07%, BIRD is doing worse than 93.88% of the companies in the same industry.
BIRD has a Return On Equity of -97.70%. This is amonst the worse of the industry: BIRD underperforms 87.76% of its industry peers.
Industry RankSector Rank
ROA -56.07%
ROE -97.7%
ROIC N/A
ROA(3y)-26.66%
ROA(5y)-19.99%
ROE(3y)-41.9%
ROE(5y)-31.15%
ROIC(3y)N/A
ROIC(5y)N/A
BIRD Yearly ROA, ROE, ROICBIRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 400 600 800

1.3 Margins

BIRD has a worse Gross Margin (44.18%) than 61.22% of its industry peers.
In the last couple of years the Gross Margin of BIRD has declined.
The Profit Margin and Operating Margin are not available for BIRD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5Y-4.06%
BIRD Yearly Profit, Operating, Gross MarginsBIRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BIRD has been reduced compared to 1 year ago.
BIRD has less shares outstanding than it did 5 years ago.
There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BIRD Yearly Shares OutstandingBIRD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M
BIRD Yearly Total Debt VS Total AssetsBIRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

BIRD has an Altman-Z score of -2.50. This is a bad value and indicates that BIRD is not financially healthy and even has some risk of bankruptcy.
BIRD's Altman-Z score of -2.50 is on the low side compared to the rest of the industry. BIRD is outperformed by 87.76% of its industry peers.
BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.5
ROIC/WACCN/A
WACC9.98%
BIRD Yearly LT Debt VS Equity VS FCFBIRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.39 indicates that BIRD has no problem at all paying its short term obligations.
BIRD has a Current ratio of 3.39. This is amongst the best in the industry. BIRD outperforms 91.84% of its industry peers.
BIRD has a Quick Ratio of 2.13. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.
BIRD's Quick ratio of 2.13 is amongst the best of the industry. BIRD outperforms 89.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 2.13
BIRD Yearly Current Assets VS Current LiabilitesBIRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

BIRD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.46%, which is quite good.
BIRD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.67%.
The Revenue has been growing by 68.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)12.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.56%
Revenue 1Y (TTM)-22.67%
Revenue growth 3Y5.03%
Revenue growth 5Y68.35%
Sales Q2Q%-24.88%

3.2 Future

The Earnings Per Share is expected to grow by 18.65% on average over the next years. This is quite good.
BIRD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.43% yearly.
EPS Next Y18.79%
EPS Next 2Y12.51%
EPS Next 3Y13.48%
EPS Next 5Y18.65%
Revenue Next Year-24.9%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.38%
Revenue Next 5Y15.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BIRD Yearly Revenue VS EstimatesBIRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M 400M 500M
BIRD Yearly EPS VS EstimatesBIRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BIRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BIRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIRD Price Earnings VS Forward Price EarningsBIRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIRD Per share dataBIRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRD's earnings are expected to grow with 13.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.51%
EPS Next 3Y13.48%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BIRD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLBIRDS INC-CL A

NASDAQ:BIRD (2/21/2025, 8:03:32 PM)

6.61

-0.29 (-4.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners39.03%
Inst Owner Change-34.27%
Ins Owners1.08%
Ins Owner Change-4.29%
Market Cap52.42M
Analysts48.89
Price Target9.18 (38.88%)
Short Float %14.47%
Short Ratio13.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.07%
Min EPS beat(2)17.38%
Max EPS beat(2)32.77%
EPS beat(4)4
Avg EPS beat(4)24.12%
Min EPS beat(4)17.38%
Max EPS beat(4)32.77%
EPS beat(8)8
Avg EPS beat(8)19.04%
EPS beat(12)10
Avg EPS beat(12)14.33%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.85%
Min Revenue beat(2)0.11%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-2.66%
Max Revenue beat(4)2.2%
Revenue beat(8)5
Avg Revenue beat(8)-0.56%
Revenue beat(12)7
Avg Revenue beat(12)0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.18%
PT rev (3m)-30.77%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)0.1%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-12.08
EYN/A
EPS(NY)-11.01
Fwd EYN/A
FCF(TTM)-7.82
FCFYN/A
OCF(TTM)-7.28
OCFYN/A
SpS25.96
BVpS16.06
TBVpS16.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.07%
ROE -97.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.18%
FCFM N/A
ROA(3y)-26.66%
ROA(5y)-19.99%
ROE(3y)-41.9%
ROE(5y)-31.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.23%
GM growth 5Y-4.06%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.68%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.39
Quick Ratio 2.13
Altman-Z -2.5
F-Score4
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)171.98%
Cap/Depr(5y)221.3%
Cap/Sales(3y)7.84%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.56%
EPS Next Y18.79%
EPS Next 2Y12.51%
EPS Next 3Y13.48%
EPS Next 5Y18.65%
Revenue 1Y (TTM)-22.67%
Revenue growth 3Y5.03%
Revenue growth 5Y68.35%
Sales Q2Q%-24.88%
Revenue Next Year-24.9%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.38%
Revenue Next 5Y15.43%
EBIT growth 1Y11.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.54%
EBIT Next 3Y18.49%
EBIT Next 5Y18.41%
FCF growth 1Y47.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.02%
OCF growth 3YN/A
OCF growth 5YN/A